RBS Global Big Pharma ETN (DRGS)
- Global Equity | Health/Biotechnology Funds
The investment seeks to replicate, net of expenses, the NYSE Arca Equal Weighted Pharmaceutical Total Return Index. The index is designed to track the performance of the equity securities of a cross section of companies involved in various phases of development, production and marketing of pharmaceuticals, with the component securities represented in approximately equal dollar amounts.
Fund Snapshot Updated 12.11.2013
|Previous Close||$39.56||Expense Ratio||0.60%|
|YTD Return||34.9%||Avg. 30-Day Volume||2,014|
|1-Year Return||32.6%||Market Cap||Loading...|